贝瑞基因 (000710)
Berry Genomics Co.,Ltd
K-Line Chart
No K-line data available
Company NameChengdu Berry & Kang Gene Technology Co., Ltd.
Listing Date1997-04-22
Issue Price5.1RMB
Registered Capital35352.146510k RMB
Legal RepresentativeGao Yang
Registered AddressNo. 333 Chengdu Automobile City Avenue, Chengdu Economic and Technological Development Zone (Longquanyi District), Sichuan Province
IndustryMedical Services
Main BusinessGene testing and equipment, reagent sales based on high-throughput sequencing technology.
Company ProfileChengdu Berry & Kang Gene Technology Co., Ltd. is an advanced innovative biotechnology company dedicated to the comprehensive transformation of gene sequencing technology into practical applications, focusing on promoting life science research through sequencing technology. Relying on innovative sequencing technology, precise testing methods, and a rigorous scientific attitude, the company ultimately aims to serve the greater health of humanity. As a pioneering enterprise in China's gene sequencing industry, Berry Genomics consistently upholds the spirit of active innovation and determined progress, maintaining a leading edge while guiding the development of the industry.
Stock Details
1. Key Indicators
- Total Shares(W): 35352.15
- Circulating A-Shares(W): 32952.99
- Earnings Per Share(RMB): -0.1487
- Net Assets Per Share(RMB): 4.5814
- Operating Revenue(W RMB): 68565.68
- Total Profit(W RMB): -4328.59
- Net Profit Attributable to Parent(W RMB): -5256.37
- Net Profit Growth Rate(%): -606.13
- Weighted Return on Equity(%): -3.1800
- Operating Cash Flow Per Share(RMB): -0.0700
- Undistributed Profit Per Share(RMB): 0.0339
- Capital Reserve Per Share(RMB): 3.2657
2. Main Business
The main business covers:
- Gene detection services based on high-throughput sequencing technology
- Gene detection services based on third-generation HiFi sequencing technology
- Sales of equipment related to gene detection
- Sales of reagents related to gene detection
- Sales of software related to gene detection
3. Company Basic Information
- Company Name: Berry Genomics Co., Ltd.
- Listing Date: 1997-04-22
- Industry: Medicine & Medical Care - Medical Services (TDX Research Industry) / Professional Technical Services (CSRC Industry)
- Address: Office Address: Building 5, No. 4 Life Science Park Road, Changping District, Beijing
- Website: www.berrygenomics.com
- Company Profile：The company's predecessor was Sichuan Tianxing Instrument Factory. In 1995, it began restructuring into a joint-stock company, converting its productive net assets and part of its equity in Shanghai Wanyou Tianxing Instrument Co., Ltd. into state-owned shares (initially 31.55 million shares, later changed to 42.50 million shares). After the initial online pricing issuance on April 2, 1997, the total number of shares at the time of listing was 60 million shares; 1.75 million employee shares were to be listed for trading six months after the public shares were listed.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Chengdu Tianxing Instrument (Group) Co., Ltd. | General Legal Person | 4400.20 | 13.35 |
| 2 | Hongling Siqi (Zhuhai) M&A Equity Investment Enterprise (Limited Partnership) | General Legal Person | 3000.00 | 9.10 |
| 3 | Shanghai Tianyihe Information Technology Co., Ltd. | General Legal Person | 271.88 | 0.83 |
| 4 | Pingtan Tianqi Rui Investment Partnership (Limited Partnership) | General Legal Person | 200.00 | 0.61 |
| 5 | Yongwin CSI All Share Medical Devices Tradable Open-End Index Securities Investment Fund | Fund | 152.68 | 0.46 |
| 6 | ||||
| 7 | ||||
| 8 | ||||
| 9 | ||||
| 10 |
5. Concept Sectors
- Infant & Child Concept
- Gene Concept
- Artificial Intelligence
- Big Data
- Tencent Concept
- Assisted Reproduction
- Data Element
- Zhipu AI
- AI Agent
- DeepSeek
- AI Medical
- Consecutive Losses
- Long-Term No Dividend
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information